# Pfizer Asia Manufacturing Pte Ltd. – FDA Inspection, Oct 27, 2021

Source: https://www.keypedia.com/records/fda_inspections/pfizer-asia-manufacturing-pte-ltd/6ecd8529-b24e-4f45-a1dc-6dbc45d8e796
Source feed: FDA_Inspections

> FDA inspection 1156359 of Pfizer Asia Manufacturing Pte Ltd., October 27, 2021. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1156359
- Company Name: Pfizer Asia Manufacturing Pte Ltd.
- Inspection Date: 2021-10-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1085293 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/pfizer-asia-manufacturing-pte-ltd/7d96dea7-3b07-46be-8bd4-730b14818479)
- [FDA Inspection 1009110 - 2017-03-24](https://www.keypedia.com/records/fda_inspections/pfizer-asia-manufacturing-pte-ltd/b00b5e91-d015-4ad2-979b-9e595cd785a1)
- FDA Inspection 955761 - 2015-12-03
- [FDA Inspection 825350 - 2013-03-01](https://www.keypedia.com/records/fda_inspections/pfizer-asia-manufacturing-pte-ltd/79a2f83e-dfb5-49c2-b8c0-ada3fd1e6753)
- FDA Inspection 580783 - 2009-03-19

Company: https://www.keypedia.com/companies/pfizer-asia-manufacturing-pte-ltd/77c4ecfd-af67-404b-8091-9c254525198b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c